Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
G-CSF subcutaneous versus intrauterine administration in women with idiopathic infertility undergoing IUI
IRCT20200303046688N1Phase 3Completed
- Sponsor
- Hormozgan University of Medical Sciences
- Start
- Apr 2019
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, randomised, single-blind trial of granulocyte colony-stimulating factor in Unexplained infertility (4 arms), sponsored by Hormozgan University of Medical Sciences. Primary endpoints: Endometrial thickness, Chemical pregnancy and 1 more. Started Apr 2019; status: completed.
02
Drugs
granulocyte colony-stimulating factor
03
Conditions
Unexplained infertility
Beyond the preview
Go deeper on IRCT20200303046688N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20200303046688N1.